{"disease":{"id":"recurrent-idh1-2-mutated-glioma","name":"recurrent idh1 2 mutated glioma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03666559","title":"Treatment With Azacitidine of Recurrent Gliomas With IDH1/2 Mutation","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":8,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}